Gabapentin Tablet, Film Coated
Product Images NDC 80425-0097

10 FDA label images from Advanced Rx Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0097). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

Fig 1
This line graph depicts weekly mean pain scores over an 8-week period in a study population. It compares a placebo group versus a Gabapentin 3600 mg/day group during a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10, and the x-axis shows weeks from baseline to week 8.*
FDA Label Image

Fig 2

Fig 2
A line graph depicting weekly mean pain scores over seven weeks in a clinical study population. The graph compares three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. It shows a 3-week dose titration period followed by a 4-week fixed dose period, illustrating changes in mean pain scores from baseline through week 7.*
FDA Label Image

Fig 3

Fig 3
A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares response rates between placebo (PBO) and gabapentin (GBP) at different dosages (3600 mg, 1800 mg, and 2400 mg) across two studies, showing higher responder proportions in gabapentin groups with statistical significance indicated.*
FDA Label Image

Fig 4

Fig 4
A scatter plot graph titled 'Responder Rate in Patients Receiving Gabapentin Expressed as Difference from Placebo by Dose and Study' showing data points for three studies (a, b, c). The x-axis represents daily dose in mg (600 to 1800 mg), and the y-axis shows the difference in responder rate (%) from placebo. The chart compares the effect of gabapentin doses on patients aged 12 years and older with partial seizures across different studies.*
FDA Label Image

Formula

Formula
An equation illustrating the calculation of creatinine clearance (CLCr) based on age, weight, serum creatinine, and an adjustment factor for female patients. This formula is used to estimate kidney function.*
FDA Label Image

Gabapentin 600mg Tab Qty 120 Ndc 80425 0097

Gabapentin 600mg Tab Qty 120 Ndc 80425 0097
Gabapentin 600 mg film-coated tablets label from Advanced Rx of Tennessee, LLC. The label includes the proprietary and generic name, 120 count, NDC 80425-0097, lot number, expiration date 6/30/2023, storage instructions (20°-25°C), and a QR code. It also notes comparison to Neurontin and includes a caution about federal law prohibiting transfer of the drug.*
FDA Label Image

Gabapentin 600mg Tab Qty 30 Ndc 80425 0097

Gabapentin 600mg Tab Qty 30 Ndc 80425 0097
Label for Gabapentin 600 mg film-coated tablets, package of 30, manufactured by Advanced Rx of Tennessee, LLC. The label includes the NDC 80425-0097, lot number 30GP600423, and expiration date 4/30/2023. Storage instructions advise room temperature 20°-25°C (68°-77°F).*
FDA Label Image

Gabapentin 600mg Tab Qty 60 Ndc 80425 0097

Gabapentin 600mg Tab Qty 60 Ndc 80425 0097
Label for Gabapentin 600 mg film-coated tablets, 60 count, from Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0097, batch lot G600623 with expiration 6/30/2023, and storage instructions at 20°-25°C (68°-77°F). The label also notes it is comparable to Neurontin 600 mg tablets.*
FDA Label Image

Gabapentin 600mg Tab Qty 90 Ndc 80425 0097

Gabapentin 600mg Tab Qty 90 Ndc 80425 0097
Label for Gabapentin 600 mg film-coated tablets, package of 90, manufactured by Advanced Rx of Tennessee, LLC. The label includes the product NDC 80425-0097, lot number 90GP600723, expiration date 7/31/2023, storage instructions to keep at 20°-25°C (68°-77°F), and a barcode. It also contains a federal law caution restricting dispensing.*
FDA Label Image

Structure

Structure
Chemical structure of gabapentin showing a cyclohexane ring with amino and carboxymethyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.